Cost effective analysis of Apixaban versus Warfarin for the prevention of stroke as a result of atrial fibrillation: A systematic review

Authors

F. Ellen Loh, Touro College of PharmacyFollow
L. Petrenchik, Touro College of Pharmacy

Document Type

Presentation

Publication Date

5-21-2018

Recommended Citation

Loh, F. E., Petrenchik, L., Hussain, N., Charles, P., & Peprah, H. (2018, May 21). Cost effective analysis of Apixaban versus Warfarin for the prevention of stroke as a result of atrial fibrillation: A systematic review. Presentation at the ISPOR 23rd Annual International Meeting, Baltimore, Maryland.